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Objective: Glucose is an important substrate for energy production in the developing
heart. Increased glucose uptake rate and metabolism during ischemia and reperfu-
sion are closely linked to postischemic myocardial recovery. The initial rate-limiting
step for glycolysis is the transport of glucose across the plasma membrane by
glucose transporters (GLUT-1 and GLUT-4). We hypothesized that changes in
GLUT-1 and GLUT-4 expression in developing hearts lead to age-dependent
adaptive changes in glucose uptake capacity and influence tolerance to ischemia.
Methods: Western-immunoblotting was performed to determine GLUT-1 and
GLUT-4 expression in myocardial tissue from 1, 2, and 3-week-old and adult
rabbits. Glucose uptake rate was measured with 31P-nuclear magnetic resonance
spectroscopy using 2-deoxyglucose as substrate in isolated perfused hearts. Hearts
from same age rabbits were perfused in the Langendorff mode with crystalloid
buffer or buffer plus a GLUT-4 specific antibody in order to determine GLUT-4
mediated effects on myocardial protection. The hearts were subjected to 30 minutes
of normothermic ischemia followed by reperfusion. Cardiac contractile function
measurements were obtained pre- and postischemia. Tissue lactate accumulation
was measured in all groups at end-ischemia
Conclusions: Insulin-regulated glucose transporter (GLUT-4) expression in the
heart increased gradually after birth reaching nearly adult levels by 3 weeks of age.
Corresponding with the higher amount of GLUT-4 protein, improved recovery of
postischemic contractile function was seen in older hearts in association with
increased anaerobic glycolytic capacity. Interventions to accelerate postnatal
GLUT-4 expression may improve ischemic tolerance in the neonatal heart.
Ischemia induces multiple changes in myocardial cell metabolism includinga marked increase in glucose uptake and utilization.1-3 During ischemia,and particularly during early reperfusion, there is a shift in myocardialsubstrate utilization from free fatty acid oxidation to dependence on gly-colysis for energy production.4 It has been shown experimentally thatincreased glucose uptake and glycolysis during ischemia and early reper-
fusion are associated with improved postischemic myocardial recovery.3,5,6 Devel-
opmentally, age-dependent differences in the vulnerability of myocardium to isch-
emic injury have been suggested.7-9 Clinical reports suggest that in the early
neonatal period, the heart is more vulnerable to injury from global ischemia than the
mature myocardium.10-12 Lower levels of high-energy phosphates have been de-
tected in infants compared to adults undergoing cardiac surgery.12 Experimentally,
in various species, the onset of ischemic contracture due to formation of rigor
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complexes and depletion of high-energy phosphates has
been shown to occur earlier in neonatal hearts compared to
adults.8,13,14 Paradoxically, greater anaerobic glycolytic ca-
pacity and higher glycogen reserves have been demon-
strated in the neonatal hearts and potentially this may pro-
vide an advantage over adult hearts with respect to tolerance
to ischemic injury.3,15,16
Under physiologic conditions, the myocardium of neo-
natal animals has a high capacity to utilize glucose, while
adult myocardium utilizes primarily fatty acids as its energy
source. Forty-eight percent of adenosine triphosphate (ATP)
production in the myocardium of a neonatal rabbit is de-
rived from glycolysis as compared to 20% in the adult.17
There are also significant differences in the levels of circu-
lating substrates during cardiac development and matura-
tion.18,19 Whether the transition in substrate utilization from
neonatal to adult myocardium depends on changes in sub-
strate availability or in intracellular substrate utilization
remains to be determined. There is evidence that adaptive
changes in intracellular metabolic signals that coordinate
carbohydrate and fatty acid utilization in the myocardium
occur during development.20,21
The transport of glucose across the plasma membrane is
the initial step in myocardial glucose metabolism, and the
number of facilitative glucose transport proteins present in
the sarcolemma determines the rate of glucose uptake. Two
glucose transporters are expressed in cardiomyocytes, the
ubiquitous GLUT-1 and the insulin-regulated transporter
GLUT-4. It has been shown that GLUT-1 and GLUT-4 have
different affinity for glucose and transport capacity, and that
GLUT-4 is the transporter most responsible for glucose
uptake in mature myocardium. These findings suggest that
the two glucose transporters expressed in the heart play
different roles under physiologic and nonphysiologic con-
ditions.22 For example, it has been shown that ischemia
causes substantial translocation of the insulin-responsive
glucose transporter (GLUT-4) to the plasma membrane re-
sulting in greater glucose transport capacity.23
The present study was undertaken to determine the coordi-
nate expression of GLUT-1 and GLUT-4 in the developing
rabbit heart. We tested the hypothesis that developmentally
regulated differences in glucose transporter expression af-
fect glucose uptake rate and correlate with susceptibility to
ischemia/reperfusion injury during maturation. To determine
this relationship, we measured glucose transporter protein
content, and insulin-stimulated glucose transport rate. Tis-
sue lactate production during the ischemic period was mea-
sured as an indicator of anaerobic glycolytic activity.
Materials and Methods
Myocardial GLUT-1 and GLUT-4 Content by
Western-Immunoblotting
New Zealand White rabbits of either sex at different time points in
their development (1-day, 1-, 2-, 3-, 4-week-old, and adult) were
studied. Following intravenous or intraperitoneal administration of
a mixture of heparin (500 U/kg), ketamine (50 mg/kg), and xyla-
zine (2.5 mg/kg), the hearts were rapidly removed flushed with
cold Krebs-Henseleit (KH) buffer solution and the left ventricles
(LV) were frozen in liquid nitrogen. LV tissue was further pro-
cessed as previously described and 25 g protein from the crude
supernatant fraction was then used for gel electrophoresis with
10% sodium dodecyl sulfate (SDS) polyacrylamide gel electro-
phoresis gels.24,25 After transfer to nitrocellulose membranes, the
membranes were incubated in 5% nonfat dry milk in TBST (10
mmol/L Tris-HCl pH 7.5, 100 mmol/L NaCl, 0.1% Tween 20) to
block unspecific binding sites and then with primary antibodies to
either GLUT-1 (East Crest, Mass) or GLUT-4 (R&D Systems Inc.,
Minneapolis, Minn) at a dilution of 1:1000 followed by incubation
with horseradish peroxidase-conjugated secondary antibody (Jack-
son Immuno Research Labs, Inc., West Grove, Penn) at a dilution
of 1:10000. The bound antibody was detected by the enhanced
chemoluminescence method according to the manufacturer’s in-
struction (Amersham Life Science, Arlington Heights, Ill). After
exposure on films, quantitative protein analysis was performed by
laser densitometry.
2-Deoxyglucose Uptake
Glucose uptake was determined by 31P-nuclear-magnetic-reso-
nance (NMR) spectroscopy using 2-deoxyglucose (2-DG) as sub-
strate. We have previously described and validated this method in
detail.24 Nonischemic hearts from 1-week-old (age range, 3-5
days), 2-week-old (age range, 14-15 days), 3-week-old (age range,
20-21 days), and adult rabbits (age range, 6 weeks to 6 months)
were positioned within a 20-mm solenoid radiofrequency coil.
NMR spectra were acquired in an 8.45-Tesla vertical bore Bruker
spectrometer (Bruker Instruments, Billerica, Mass) operating at a
proton frequency of 360 MHz and 31P frequency of 145 using
ketamine (50 mg/kg) and xylazine (2.5 mg/kg) for euthanasia with
the addition of heparin (500 U/kg). The hearts were rapidly excised
and perfused with oxygenated KH solution containing glucose (10
mmol/L) but no insulin. After a 30-minute stabilization period, the
perfusate was switched to a modified KH solution containing
bovine insulin (10 IU/L), a reduced glucose content (1 mmol/L)
and a concentration of 3 mmol/L 2-DG (Sigma, Chemical Com-
pany, St. Louis, Mo). The rate of 2-DG accumulation (proportional
to the rate of glucose uptake) was quantified by a second order
polynomial function.
Isolated Heart Preparation and Cardiac Function
Measurements
One-, 2-, 3-week-old, and adult rabbits were studied. Following
intravenous or intraperitoneal administration of heparin (500
U/kg), ketamine (50 mg/kg), and xylazine (2.5 mg/kg) the hearts
were rapidly excised. After aortic cannulation the hearts were
perfused in the nonworking, nonrecirculating Langendorff mode at
constant flow perfusion with oxygenated KH solution (37°C, pH
7.4, containing: 11 mmol/L glucose, 10 IU/L insulin). In separate
sets of experiments, GLUT-4 antibody (R&D Systems Inc.) in a
concentration of 0.2 g/mL was added to the perfusate. The
concentration was chosen based on previous experiments that
proved a significant impairment of postischemic recovery could be
achieved without influencing preischemic contractility. Perfusion
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rate was normalized for the absolute weight of the heart and
thereby maintained equal for all hearts (10 mL · min1 · g1 heart
weight). Constant flow rate was maintained with a roller pump
(Master Flex; Cole Parmer, Chicago, Ill).
LV pressure measurements were obtained with a latex balloon
inserted into the LV cavity and connected to a catheter tip pressure
transducer (Millar Instruments Co, Houston, Tex). Heart rate and
LV developed pressure (calculated from LV systolic pressure
minus diastolic pressure) at balloon volumes adjusted to produce a
diastolic pressure in the range of 5 to 10 mm Hg, were determined
after a 30-minute stabilization period as baseline measurements.
After induction of ischemia, the intracavitary balloon was emptied
and remained empty during the entire ischemic period and during
reperfusion to simulate the beating, nonworking heart. Hearts were
maintained at 36.5°C  0.5°C for 30 minutes and reperfused for
30 minutes. At the end of reperfusion, the balloon was inflated to
its preischemic volume and intracavitary pressure data were re-
corded and compared with baseline data. Hearts were weighed
prior to and after a 48-hour drying period to calculate wet weight/
dry weight ratios.
Lactate Measurements
At end-ischemia coronary effluent of first minute reperfusion was
collected and a sample of the LV myocardium was snap frozen in
liquid nitrogen. The frozen tissue was further processed with 6%
hydrochloric acid and lactate content of effluent and LV myocar-
dial sample were determined by a colorimetric kit (Sigma Chem-
ical Company).
Statistical Analysis
Data are expressed as the mean  SEM and analyzed using SPSS
software (version 9.0; SPSS Inc, Chicago, Ill). Comparisons be-
tween groups were made with one-way analysis of variance. P
values were corrected by Bonferroni’s post hoc correction. If
normal distribution and equal variance testing was passed, a stan-
dard t test was used.
Animal Care
All animals received humane care in compliance with the Princi-
ples of Laboratory Animal Care formulated by the National Soci-
ety for Medical Research and the Guide for the Care and Use of
Laboratory Animals prepared by the National Academy of Sci-
ences and published by the National Institutes of Health (NIH
Publication No. 86-23, revised 1996). The protocol was reviewed
and approved by the Animal Care Committee at Children’s Hos-
pital Boston.
Results
Myocardial GLUT-1 and GLUT-4 Content
GLUT-1 and GLUT-4 protein content in LV myocardium
from rabbits of different ages is shown in Figures 1 and 2.
Figure 1. A, Representative Western-immunoblot of GLUT-1 glucose transporter from LV myocardium of rabbits at
different ages. B, Quantitation of GLUT-1 levels on immunoblots was performed by laser densitometry and is
summarized in this bar graph. Results are expressed in arbitrary densitometry units (n 6/group; *P< .05 vs 1 day
and 1 week; #P < .05 vs 2 weeks).
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There was a decline in GLUT-1 protein content with mat-
uration. GLUT-1 protein levels were lower starting at 2
weeks after birth compared to 1 day and 1 week old rabbits
(P  .05 vs 1 day and 1 week). Coincident with the decline
in GLUT-1 protein levels, there was an increase in GLUT-4
protein content, reaching almost adult levels by 3 weeks.
The switch from predominantly GLUT-1 to GLUT-4 ex-
pression occurred at about 2 weeks.
2-DG Uptake
Figure 3 shows the rate of insulin-stimulated 2-deoxyglu-
cose-6-phosphate (2-DG-6-P) accumulation over a period of
30 minutes in isolated rabbit hearts at different time points
in their development (1 week, 2 weeks, 3 weeks, adult).
Glucose uptake as indicated by 2-DG-6-P accumulation was
lower in 1-week-old hearts compared to all other age groups
with a slower rate of rise and lower total accumulation after
30 minutes of perfusion with 2-DG (P  .05). By 3 weeks,
insulin-stimulated 2-DG-6-P accumulation had already
reached almost adult levels.
Contractile Function
Preischemic contractile function measurements recorded af-
ter a 30-minute stabilization period are summarized in Table
1. Hearts from 1-week-old rabbits had lower left ventricular
developed pressure (calculated from systolic minus diastolic
pressure) preischemia compared to all other age groups (P
 .05).
After 30 minutes of normothermic ischemia, and 30
minutes of reperfusion, in all four age groups, diastolic
pressure increased compared to preischemic baseline values
(P  .05; data not shown) and there was no difference
between the age groups. There was no difference in dry
weight to wet weight ratios pre- or postischemia between
the groups (data not shown).
Postischemic developed pressure was lower in 1-week-
old hearts compared to baseline measurements (73  6 mm
Hg preischemia vs 44  2 mm Hg postischemia; P  .05).
Two-week-old and adult hearts had better recovery of de-
veloped pressure postischemia (92  1 mm Hg vs 73  4
mm Hg, pre- vs postischemia; and 92  2 mm Hg vs 77 
4 mm Hg pre- vs postischemia, respectively) compared to
Figure 2. A, Representative Western-immunoblot of GLUT-4. Glucose transporter from LV myocardium of rabbits at
different ages. B, Quantitation of GLUT-4 levels on immunoblots was performed by laser densitometry and is
summarized in this bar graph. Results are expressed in arbitrary densitometry units (n 6/group; *P< .05 vs 1 day
and 1 week; #P < .05 vs 2 weeks).
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1-week-old (P  .05). In hearts from 3-week-old rabbits
developed pressure recovered to preischemic levels (92  2
mm Hg vs 81  3 mm Hg, pre- vs postischemia). Devel-
oped pressure during reperfusion, expressed as percent re-
covery from preischemic values is depicted in Figure 4, A.
One-week-old hearts had the poorest recovery (62%  5%)
of all age groups (P  .05). The addition of GLUT-4
antibody to the perfusate did not affect postischemic func-
tion in 1-week-old hearts, however, GLUT-4 antibody sig-
nificantly impaired postischemic functional recovery of
adult hearts (P  .05; Figure 4, B).
Myocardial Tissue Lactate Levels at End-Ischemia
Tissue lactate levels at end-ischemia are depicted in Figure
5, A. The highest levels of lactate were found in the adult
LV myocardium. Blocking GLUT-4 transporters with
GLUT-4 antibodies in the perfusate had no effect on tissue
lactate accumulation during ischemia in 1-week-old hearts
but significantly decreased tissue lactate levels in adult
hearts (P  .05; Figure 5, B).
Discussion
In this study we have demonstrated that GLUT-1 is the
predominant glucose transporter expressed in neonatal rab-
bit myocardium. By 2 weeks of age, GLUT-4 expression
reached adult levels and GLUT-1 expression declined pro-
gressively to adult levels as well. With maturation, glucose
uptake increased and paralleled the rise in GLUT-4 expres-
sion. Increased GLUT-4 content in myocardium correlated
closely with increased anaerobic glycolytic capacity and
improved tolerance to ischemia.
In mammalian cells, glucose is not freely permeable
across the plasma membrane but must enter by facilitated
diffusion. Glucose transporter proteins that facilitate the
movement of glucose across the plasma membrane in an
energy independent manner are responsible for this process.
The various members of the glucose transporter family have
distinct structure, function, and tissue distribution.22,26-28 In
the adult heart, GLUT-1 is present in low levels and is
responsible for “basal” glucose uptake.29 GLUT-4, the in-
sulin-regulated transporter, is expressed in cells that can
rapidly increase glucose transport across the plasma mem-
brane, such as skeletal, and cardiac myocytes, and adipo-
cytes.30 In cardiac myocytes, in the basal state, GLUT-1 is
evenly distributed between the plasma membrane and low-
density microsomal pools whereas GLUT-4 is almost en-
tirely stored in an intracellular pool.31,32 Insulin interaction
with its membrane receptor results in rapid translocation of
Figure 3. 2-Deoxyglucose uptake rate and phosphorylation was measured as accumulation of 2-deoxyglucose-6-
phosphate by 31P-NMR spectroscopy over a period of 30 minutes in hearts at different ages (1 week, 2 weeks, 3
weeks, adult). n  6/group, *P < .05 vs 2 weeks, 3 weeks, and adult.
TABLE 1. Baseline cardiac function measurements
1 week 2 weeks 3 weeks Adult
HR 201 5* 197 5* 200 4* 148 7
DP 6 0.5 7 0.8 6 0.7 7 0.2
DevP 73 6* 92 1 92 2 92 2
HR, Heart rate; DP, diastolic pressure; DevP, developed pressure (systolic-
diastolic pressure).
Values are expressed as mean  SEM (n  6/group).
*P  .05; vs adult.
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GLUT-4 containing intracellular vesicles to the cell mem-
brane. After cessation of stimulation, GLUT-4 is reseques-
tered into the intracellular vesicles.33
GLUT-1 is the predominant isoform in muscle and adi-
pocytes perinatally.34 This high expression of GLUT-1 is
common in not only insulin-responsive tissues like the
heart, skeletal muscle, or adipocytes but has also been
shown in rat and rabbit brain, lung, liver, and kidney.35,36 In
all these tissues GLUT-1 levels rapidly diminish after birth.
In skeletal muscle, GLUT-1 regression occurs concomi-
tantly with an increase in GLUT-4 expression.34 Our results
are consistent with these findings and indicate that during
early neonatal life, GLUT-1 is the predominantly expressed
isoform in myocardium. During the fetal and early neonatal
period, tissues such as heart and diaphragm have a high rate
of glucose uptake and utilization, greater than that seen in
mature tissues.37
The factors that trigger GLUT-4 induction and GLUT-1
regression during perinatal development are unknown. Pre-
viously published data suggest that thyroid hormone may
play a role in the regulation of muscle glucose transporters
during development. GLUT-1 and GLUT-4 gene expression
is highly sensitive to thyroid hormone manipulation during
perinatal life.38 T3 and T4 levels increase progressively early
after birth and reach a plateau by 2 weeks of age.39 In rat
heart and skeletal muscle, hypothyroidism induced at birth
leads to alterations in glucose transporter expression with
GLUT-4 expression being blocked and GLUT-1 carriers
being augmented and concomitantly, glucose uptake in re-
sponse to insulin is impaired.38,40
Several studies have demonstrated that the uptake of
glucose by the mature heart is regulated by insulin via
GLUT-4 activation and by enhancing incorporation of glu-
cose transporter into the sarcolemma.22,30 In order to deter-
mine the contribution of GLUT-1 vs GLUT-4 on glucose
uptake, in our studies GLUT-4 transporters were blocked by
addition of a GLUT-4 specific antibody to the perfusate. In
1-week-old rabbit hearts, intervention at the level of
GLUT-4 did not influence the postischemic outcome. How-
ever, in adult hearts impairing GLUT-4 mediated glucose
Figure 4. A, Postischemic developed pressure expressed as percent of preischemic measurements of 1 week, 2
weeks, 3 weeks, and adult hearts. (n  6/group, *P < .05; vs 1 week). B, Postischemic developed pressure
expressed as percent of preischemic measurements in 1-week-old and adult hearts with and without GLUT-4
antibody present in the perfusate. (*P < .05 vs adult; #P < .05 vs 1 week  GLUT-4 antibody).
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uptake resulted in impaired postischemic myocardial recov-
ery concomitant with a decrease in anaerobic glycolytic
capacity. Enhanced glucose uptake during ischemia and
early reperfusion has been directly linked to postischemic
myocyte viability.6 Ischemia has been shown to induce a
marked increase in glucose uptake presumably to increase
substrate availability for glycolysis.6,15,41,42 The transition
from aerobic to anaerobic glycolysis leads to a 20-fold
increase in glycolytic flux.43 This increase in glucose uptake
rate is achieved by translocation of glucose transporter
containing intracellular vesicles to the sarcolemma, similar
to the effects of insulin.31,44 GLUT-1 is also activated
during ischemia but the increase in GLUT-1 translocation is
significantly lower than for GLUT-4.45
Limitations of This Study
The use of 2-DG to estimate glucose uptake into the cell is
done with 31P-NMR spectroscopy measuring 2-deoxyglu-
cose-6-phosphate accumulation. This measure assumes that
the affinity of the transporter and hexokinase are similar for
2-DG as they are for glucose, under the specific experimen-
tal conditions. In previous studies with rabbit hearts ex-
posed to the same experimental conditions, we have shown
that hexokinase activity remains constant during the 2-DG
infusion and that the 2-DG uptake rate is the same as that for
radiolabeled glucose.24 To account for the different perfu-
sion requirements of the various age hearts, perfusion rate
was matched to heart weight (10 mL · min1 · g1 heart
weight). Thus, availability of substrate and 2-DG was main-
tained the same for the different experimental groups. Fur-
thermore, because handling of small hearts is more chal-
lenging, baseline ATP levels were determined in all hearts
in order to detect differences due to tissue perfusion, and
none were found (data not shown).
Our data support the conclusion that a switch in glucose
transporter isoform expression in the postnatal heart, from
GLUT-1 to GLUT-4, leads to an increase in glucose uptake
rate and improved tolerance to ischemia. Upregulation of
the insulin-sensitive glucose transporter GLUT-4 reaches
adult levels by 3 weeks of age in the rabbit. Corresponding
with the higher amount of GLUT-4 protein, insulin-stimu-
lated myocardial glucose transport rate also reaches adult
Figure 5. A, Lactate levels measured at end-ischemia are depicted in this bar graph (*P < .05 vs adult; #P < .05
vs 1 week). B, Lactate levels measured at end-ischemia in 1-week-old and adult hearts with and without GLUT-4
antibody present in the perfusate (*P < .05 vs adult; #P < .05 vs 1 week  GLUT-4 antibody).
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levels during this time period. These results indicate that
low GLUT-4 expression after birth restricts the amount of
exogenous glucose available to the immature heart resulting
in greater vulnerability to an ischemic insult and may be an
important therapeutic target.
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